Kendall David M 4/A
4/A · MANNKIND CORP · Filed Mar 13, 2019
Insider Transaction Report
Form 4/AAmended
MANNKIND CORPMNKD
Kendall David M
Chief Medical Officer
Transactions
- Purchase
Common Stock, $0.01 Par Value
2018-11-14$1.77/sh+2,824$4,998→ 2,824 total